Refine your search
Collections
Co-Authors
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Vijayalakshmi, A.
- Bronchodilator and Mast Cell Stabilizer Effect of Siddha Formulation Seenthil Chooranam
Abstract Views :161 |
PDF Views:3
Authors
Affiliations
1 Department of Pharmacognosy, School of Pharmaceutical Sciences, VISTAS, Vels University, Pallavaram, Chennai-117, Tamilnadu, IN
1 Department of Pharmacognosy, School of Pharmaceutical Sciences, VISTAS, Vels University, Pallavaram, Chennai-117, Tamilnadu, IN
Source
Research Journal of Pharmacy and Technology, Vol 10, No 1 (2017), Pagination: 252-256Abstract
The present study aimed to evaluate anti-asthmatic activity of a classical Siddha formulation Seenthil chooranam (SC) by mast cell stabilizing effect and broncho dilator property by in-vivo method. Preliminary phytochemical and HPTLC analysis of SC were determined as per standard protocols. Phytochemical analysis of aqueous extract gave positive test for carbohydrates, phenols, glycosides, saponins, flavonoids, tannins and terpenoids. HPTLC finger print analysis of the aqueous extract showed the presence of possible number of components. The results of the in-vivo study demonstrate that SC has potent broncho dilator property with significant (p<0.001) mast cell stabilizing activity and decrease in leukocytosis in dose dependent manner. These findings are clearly indicative of the role of SC as potent inhibitor of mast cell degranulation and ability to control the leukocytosis, have bronchodilation and hence can be used for the management of asthma supporting the traditional claims.Keywords
Seenthil Chooranam, Siddha Formulation, Asthma, Mast Cell.- Phytochemical and Physiochemical Standardization of a Siddha Formulation Seenthil Chooranam
Abstract Views :225 |
PDF Views:0
Authors
Affiliations
1 School of Pharmaceutical Sciences, VISTAS, Vels University, Pallavaram, Chennai-117, Tamilnadu, IN
1 School of Pharmaceutical Sciences, VISTAS, Vels University, Pallavaram, Chennai-117, Tamilnadu, IN
Source
Research Journal of Pharmacy and Technology, Vol 11, No 1 (2018), Pagination: 23-26Abstract
The aim of the present study is to investigate the phytochemical and physiochemical investigation of a traditional classical Siddha formulation known as Seenthil chooranam (SC). Preliminary phytochemical analysis, HPTLC analysis and physicochemical parameters such as ash values, extractive values and loss on drying were determined as per standard protocols. The SC upon successive extraction with petroleum ether, chloroform, ethyl acetate and ethanol gave a yield of 0.05, 0.33, 1.50 and 1.90%w/w respectively. Phytochemical analysis of different extracts gave positive test for alkaloids, steroids, terpenoids, flavonoids, tannins, carbohydrates, glycosides, and proteins. HPTLC finger print analysis of the extracts showed the presence of possible number of components. Physicochemical parameters such as total ash, water soluble ash and acid insoluble ash values were found to be 2.98, 1.62 and 1.04%w/w, respectively; extractive value were found to be alcohol soluble 10.20 %w/w, water soluble- 10.24%w/w and moisture content– 0.105% w/w. The present study provides phytochemical and physicochemical details of SC which are useful in laying down standardization and pharmacopoeia parameters.Keywords
Seenthil chooranam, Siddha Formulation, Standardization, HPTLC.References
- Ariyanathan S, Saraswathy A and Rajamanickam GV. Quality control standards for the ischolar_mains of three Plumbago species. Indian Journal of Pharmaceutical Science 2010; 72: 86-91.
- Arun Rasheed, Sravya Reddy B and Roja C. A review on standardization of herbal formulation. Inter. Journal of Phytotherapy 2012; 2(2): 74-88.
- Harborne JB. Phytochemical methods: A guide to modern techniques of plant analysis. London: Chapman and Hall 1984.
- Rich E and Schibli A. HPTLC for the Analysis of Medicinal Plants. Thieme Medical Publisher, Inc, ISBN 13:978-1-58890-409-6(US) 2008.
- Quality control methods for medicinal plant materials WHO. Indian edition. Geneva; 2004.
- Chondromalacia Patellae:A Review
Abstract Views :206 |
PDF Views:0
Authors
Affiliations
1 School of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advanced Studies (VISTAS), Pallavaram, Chennai-117, Tamilnadu, IN
2 Department of Pharmacognosy, School of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advanced Studies, Pallavaram, Chennai, Tamil Nadu, IN
1 School of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advanced Studies (VISTAS), Pallavaram, Chennai-117, Tamilnadu, IN
2 Department of Pharmacognosy, School of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advanced Studies, Pallavaram, Chennai, Tamil Nadu, IN
Source
Research Journal of Pharmacy and Technology, Vol 12, No 1 (2019), Pagination: 412-418Abstract
Chondromalacia patella (knee pain) is the softening and breakdown of the tissue (cartilage) on the underside of the kneecap (patella) and is often referred to as chondromalacia of the patella, patellofemoral syndrome, or runner's knee. Pain Results when the knee and the thigh bone (femur) rub together. Abnormal knee cap positioning, tightness or weakness of the muscles associated with the knee, too much activity involving the knee, and flat feet may increase the likelihood of chondromalacia patella. The undersurface of the patella is covered with hyaline cartilage that articulates with the hyaline cartilage covered femoral groove (trochlear groove). Post-traumatic injuries, microtrauma wear and tear, and iatrogenic injections of medication can lead to the development of chondromalacia. Chondromalacia occurs in any joint and is especially common in joints that have had trauma and deformities. Cartilage is the soft tissue padding which is present between all joint and bones and acts like a shock absorber. The cartilage experiences a lot of wear, tear and damage over time. The cartilage is essentially avascular (has no blood or nerve supply) and is therefore quite a difficult area to heal. Long term therapy is essential in ensuring healthy repair so that further complications are not experienced in the future.Keywords
Chondromalacia, Chondromalacia Patella, Knee Pain, Cartilage.References
- Duran S, Cavusoglu M, Kocadal O, Sakman B. Association between trochlear morphology and chondromalacia patella: an MRI study. Clin Imaging. 2017;41:7-10.
- Brody LT and Thein JM. Nonoperative treatment for patellofemoral pain. J Orthop Sports Phys Ther. 1998; 28: 336–344.
- Wittstein JR, O’Brien SD, Vinson EN, Garrett WE Jr. MRI evaluation of anterior knee pain: predicting response to nonoperative treatment. Skeletal Radiol. 2009; 38: 895–901.
- Centeno CJ, Busse D, Kisiday J, Keohan C, Freeman M, et al. Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells. Pain Physician. 2008; 11: 343–353.
- Pak J. Autologous adipose tissue-derived stem cells induce persistent bone- like tissue in osteonecrotic femoral heads. Pain Physician. 2012; 15:75–85.
- Fisher TF, Waterman BR, Orr JD, Holland CA, Bader J, Belmont PJ. Tibial Tubercle Osteotomy for Patellar Chondral Pathology in an Active United States Military Population. Arthroscopy. 2016; 32(11): 2342-2349.
- Wang Y, Sun JY, Zha GC. Results of Lateral Retinacular Release PlusCircumpatellarElectrocautery in Total Knee Arthroplasty without Patellar Resurfacing. J Knee Surg. 2017; 30(3):212-217.
- Reider B. A Pain in the Knee. Am J Sports Med. 2016; 44(5):1103-5.
- Petersen W, Ellermann A, Rembitzki IV, Scheffler S, Herbort M, Brüggemann GP, Best R, Zantop T, Liebau C. Evaluating the potential synergistic benefit of a realignment brace on patients receiving exercise therapy for patellofemoral pain syndrome: a randomized clinical trial. Arch Orthop Trauma Surg. 2016; 136(7):975-82.
- Crossley KM, Callaghan MJ, Van Linschoten R. Patellofemoral pain. Br J Sports Med. 2016; 50(4): 247-50.
- Glaviano NR, Kew M, Hart JM, Saliba S. Demographic and Epidemiological Trends In Patellofemoral Pain. Int J Sports PhysTher. 2015; 10(3):281-90.
- Antholz CR, Cherian JJ, Elmallah RK, Jauregui JJ, Pierce TP, Mont MA. Selective Patellar Resurfacing: A Literature Review. SurgTechnol Int. 2015; 26:355-60.
- Korean Food and Drug Administration (KFDA). Cell therapy: Rules and Regulations, Chapter 2, Section 14. Seoul, Korea, 2009; 4.
- Walsh CJ, Goodman D, Caplan AI, Goldberg VM. Meniscus regeneration in a rabbit partial meniscectomy model. Tissue Eng. 1999; 5: 327–337.
- Hong E, Kraft MC. Evaluating anterior knee pain. Med. Clin. North Am. 2014; 98(4):697-717.